| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.05. | BLINKLAB LIMITED: Letter to Shareholders & Proxy Form | - | ASX | ||
| 22.05. | BLINKLAB LIMITED: Notice of General Meeting & Proxy Form | - | ASX | ||
| 19.05. | BLINKLAB LIMITED: Therapy Evaluation for Neurodevelopmental Conditions | - | ASX | ||
| 14.05. | BLINKLAB LIMITED: BB1 to present at Stocks in the Vines Investor Access Day | - | ASX | ||
| BLINKLAB Aktie jetzt für 0€ handeln | |||||
| 01.05. | BlinkLab advances smartphone-based diagnostics for autism and ADHD | 3 | Finance News Network | ||
| 29.04. | BLINKLAB LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 23.04. | BLINKLAB LIMITED: Section 708A Notice | - | ASX | ||
| 23.04. | BLINKLAB LIMITED: Application for quotation of securities - BB1 | - | ASX | ||
| 17.04. | BLINKLAB LIMITED: BlinkLab Invited to Present at Ignite Investment Summits | - | ASX | ||
| 16.04. | BLINKLAB LIMITED: Update - Proposed issue of securities - BB1 | - | ASX | ||
| 16.04. | XFRA P41: WIEDERAUFNAHME/RESUMPTION | 123 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 16.04. | BlinkLab Raises A$17.5m to Fund FDA Autism Diagnostic Clearance and Advance ADHD Trials | 1 | smallcaps.com.au | ||
| 16.04. | BLINKLAB LIMITED: Proposed issue of securities - BB1 | - | ASX | ||
| 16.04. | BLINKLAB LIMITED: BlinkLab Secures A$17.5M to Launch Autism Diagnostic Aid | - | ASX | ||
| 14.04. | XFRA P41: AUSSETZUNG/SUSPENSION | 119 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBLINKLAB LTD O.N.... ► Artikel lesen | |
| 14.04. | BLINKLAB LIMITED: Trading Halt | - | ASX | ||
| 07.04. | BLINKLAB LIMITED: Application for quotation of securities - BB1 | - | ASX | ||
| 26.03. | BLINKLAB LIMITED: Notice of Release of Escrowed Securities | - | ASX | ||
| 24.03. | BlinkLab Commences Pivotal FDA 510(k) Validation Program with First Participant Enrolment | 4 | smallcaps.com.au | ||
| 23.03. | BLINKLAB LIMITED: Validation Program Commences-FDA 510(k) - First Participant | 3 | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 13,290 | -0,08 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| FRESENIUS | 35,610 | +0,45 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
01.06.2026 / 13:38... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,00 | +0,03 % | Morgan Stanley raises BrightSpring Health price target on valuation | ||
| GENEDX | 52,00 | 0,00 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| QTREX QUANTUM | 3,100 | +0,65 % | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | ||
| FRESENIUS MEDICAL CARE | 35,960 | -1,21 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit einem Gesamtvolumen von rund EUR 1 Milliarde in Tranchen | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Kapitalmaßnahmen / Aktienrückkäufe
Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit... ► Artikel lesen | |
| BILLIONTOONE | 90,86 | -0,29 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,860 | 0,00 % | Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment | ||
| PROGYNY | 26,210 | +0,04 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| SIEMENS HEALTHINEERS | 34,140 | -0,35 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung (EU)... ► Artikel lesen | |
| HEARTFLOW | 30,950 | -0,16 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 9,665 | 0,00 % | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| ADAPTHEALTH | 9,910 | -0,20 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
| PRIVIA HEALTH GROUP | 21,300 | -0,05 % | Privia Health Group, Inc.: Privia Health Enters New Jersey | ||
| UNITEDHEALTH | 325,80 | -0,24 % | EILMELDUNG bei Unitedhealth: Könnte die Aktie jetzt komplett einbrechen? - Meine klare Einschätzung dazu |